InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

- Current share price for NOX : $0.089

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$27 NOX CEO interview on Radiotherapy Clinical Programs 27 Apr 2018 10:28AM $0.765 $0.089 fallen by 88.37%
$27 Appendix 4C - quarterly 27 Apr 2018 8:30AM $0.765 $0.089 fallen by 88.37%
$27 St Vincent's Hospital study passes first milestone 17 Apr 2018 9:20AM $0.790 $0.089 fallen by 88.73%
$27 Notice of Extraordinary General Meeting / Proxy Form 9 Apr 2018 9:09AM $0.875 $0.089 fallen by 89.83%
$27 Change in substantial holding 6 Apr 2018 4:30PM $0.875 $0.089 fallen by 89.83%
$27 Change in substantial holding 6 Apr 2018 4:29PM $0.875 $0.089 fallen by 89.83%
$27 DARRT-1 Clinical Study commences 5 Apr 2018 10:08AM $0.895 $0.089 fallen by 90.06%
$27 NOX Mid-Year Briefings 5 Apr 2018 8:32AM $0.895 $0.089 fallen by 90.06%
$27 Section 708 Certificate 29 Mar 2018 1:52PM $0.920 $0.089 fallen by 90.33%
$27 Appendix 3B 29 Mar 2018 1:51PM $0.920 $0.089 fallen by 90.33%
$27 NOX raises $10.8 M to advance clinical program 23 Mar 2018 8:47AM $1.000 $0.089 fallen by 91.10%
$27 Trading Halt 21 Mar 2018 9:18AM $1.000 $0.089 fallen by 91.10%
$27 Evidence of Abscopal Responses in Patients 21 Mar 2018 8:30AM $1.000 $0.089 fallen by 91.10%
$27 Corporate Presentation - Post Interim Clinical Data Release 12 Mar 2018 9:47AM $1.160 $0.089 fallen by 92.33%
$27 FNN Interview with Noxopharm CEO 9 Mar 2018 12:21PM $1.250 $0.089 fallen by 92.88%
$27 NOX Reports NOX66 Clinical Data 6 Mar 2018 9:07AM $1.495 $0.089 fallen by 94.05%
$27 Trading Halt 5 Mar 2018 9:10AM $1.495 $0.089 fallen by 94.05%
$27 Update accompanying Half Year Report 23 Feb 2018 8:33AM $1.140 $0.089 fallen by 92.19%
$27 Appendix 4D and Half Year Accounts 23 Feb 2018 8:17AM $1.140 $0.089 fallen by 92.19%
$27 NOX closes $4m capital raising for US subsidiary Nyrada Inc 16 Feb 2018 8:49AM $1.120 $0.089 fallen by 92.05%
$27 Appendix 4C - quarterly 31 Jan 2018 8:30AM $1.040 $0.089 fallen by 91.44%
$27 Section 708 Certificate 25 Jan 2018 11:13AM $1.135 $0.089 fallen by 92.16%
$27 Appendix 3B 25 Jan 2018 11:13AM $1.135 $0.089 fallen by 92.16%
$27 KZA: Receipt of securities in Noxopharm Limited (NOX) 22 Jan 2018 10:04AM $0.980 $0.089 fallen by 90.92%
$27 Section 708 Certificate 18 Jan 2018 3:46PM $1.080 $0.089 fallen by 91.76%

626 - 650 of 796 results

Page 26 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.